Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
OPTN similar filings
- 11 Aug 22 Optinose Reports Second Quarter 2022 Financial Results
- 13 Jul 22 Optinose Announces that XHANCE Significantly Reduced Incidence of Exacerbations for Patients with Chronic Sinusitis in Landmark ReOpen Program
- 8 Jul 22 Optinose Announces Additional Positive Results from ReOpen2 and Initial Results from Pooled Analyses of Both Trials in the ReOpen Program
- 1 Jul 22 Termination of a Material Definitive Agreement
- 13 Jun 22 Optinose Announces Positive Top-line Results of ReOpen2, its second Phase 3 Clinical Trial of XHANCE for Treatment of Chronic Sinusitis
- 9 Jun 22 Submission of Matters to a Vote of Security Holders
- 3 Jun 22 Optinose Announces Departure of Chief Financial Officer
Filing view
External links